Update on the impact of the JAK2 mutation on signalling pathways in myeloproliferative disorders
Eur J Haematol Suppl
.
2007 Oct:(68):5-8.
doi: 10.1111/j.1600-0609.2007.00935.x.
Author
Radek Skoda
1
Affiliation
1
Experimental Hematology, Department of Research, University Hospital Basel, Basel, Switzerland. radek.skoda@unibas.ch
PMID:
17727557
DOI:
10.1111/j.1600-0609.2007.00935.x
No abstract available
Publication types
Review
MeSH terms
Animals
Humans
Janus Kinase 2 / genetics*
Janus Kinase 2 / metabolism
Mutation
Myeloproliferative Disorders / genetics*
Myeloproliferative Disorders / physiopathology*
Signal Transduction*
Substances
Janus Kinase 2